Indivior Pharmaceuticals (INDV) Inventory (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Inventory of $152.0 million for Q1 2026, down 6.75% year-over-year from $163.0 million in Q1 2025, and down 0.65% quarter-over-quarter from $153.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Inventory (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Inventory history runs 6 years deep, the most recent figure standing at $152.0 million for Q1 2026.
- In Q1 2026, Inventory fell 6.75% year-over-year to $152.0 million; the TTM figure through Mar 2026 stood at $152.0 million (down 6.75% YoY), while the FY2025 annual figure was $153.0 million, down 8.38% from the prior year.
- Inventory for Q1 2026 stood at $152.0 million, down from $153.0 million in the prior quarter.
- The five-year high for Inventory was $167.0 million in Q4 2024, with the low at $114.0 million in Q4 2022.
- The 5-year median for Inventory is $152.5 million (2025), against an average of $147.4 million.
- The sharpest annual moves came in 2024 and 2025: Inventory jumped 32.54% in 2024, then decreased 8.38% in 2025.
- Indivior Pharmaceuticals' Inventory stood at $114.0 million in 2022, then advanced by 10.53% to $126.0 million in 2023, then surged by 32.54% to $167.0 million in 2024, then fell by 8.38% to $153.0 million in 2025, then retreated by 0.65% to $152.0 million in 2026.
- Business Quant data shows INDV's Inventory at $152.0 million in Q1 2026, $153.0 million in Q4 2025, and $155.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 816.00 Mn |
| 10 | Indivior Pharmaceuticals | 4.58 Bn | 4.36 Bn | 294.00 Mn | 150.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 150.00 Mn |
| Mar 31, 2026 | 152.00 Mn |
| Dec 31, 2025 | 153.00 Mn |
| Sep 30, 2025 | 155.00 Mn |
| Jun 30, 2025 | 149.00 Mn |
| Mar 31, 2025 | 163.00 Mn |
| Dec 31, 2024 | 167.00 Mn |
| Dec 31, 2023 | 126.00 Mn |
| Dec 31, 2022 | 114.00 Mn |
| Dec 31, 2021 | 95.00 Mn |